A/Z Supraglottic airway for Hypoxia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hypoxia+3 MoreA/Z Supraglottic airway - Device
Eligibility
18 - 100
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying a new supraglottic airway device that has an opening that allows access to the endotracheal tube. This could potentially simplify conversion from supraglottic to endotracheal ventilation.

Eligible Conditions
  • Hypoxia
  • Hypoventilation
  • Ventilation Therapy Complications
  • Airway Complication of Anesthesia

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: During and immediately after the intervention

During and immediately after intervention
Rate of successful exchange from endotracheal to supraglottic ventilation using A/Z modified SGA
Rate of successful exchange from supraglottic to endotracheal ventilation using A/Z modified SGA
During and immediately after the intervention
Test effect of A/Z modification of supraglottic airway device on rate of successful oxygenation and ventilation before beginning a full clinical trial

Trial Safety

Trial Design

1 Treatment Group

A/Z Airway
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: A/Z Supraglottic airway · No Placebo Group · N/A

A/Z Airway
Device
Experimental Group · 1 Intervention: A/Z Supraglottic airway · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during and immediately after the intervention

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
950 Previous Clinical Trials
1,409,702 Total Patients Enrolled
3 Trials studying Hypoxia
765 Patients Enrolled for Hypoxia

Eligibility Criteria

Age 18 - 100 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The person is scheduled to have a general anesthesia procedure with an endotracheal tube and muscle relaxation.